Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro

Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro

Background: Aspirin(acetylsalicylic acid, ASA) is recommended for the secondary prevention of atherothrombotic events and has shown anticancer effects. The current enteric-coated drug formulation may reduce aspirin bioavailability. Liquid formulations could improve aspirin pharmacokinetics and pharm...

Full description

Bibliographic Details
Main Authors: Ulrika Hofling, Stefania Tacconelli, Annalisa Contursi, Annalisa Bruno, Matteo Mucci, Patrizia Ballerini, Simon Cohen, Paola Patrignani
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Pharmacology
Subjects:
aspirin
IP1867B
platelet
serum
HCA7 cells
cyclooxygenases
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1070277/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1070277/full

Similar Items